Archived Newsletters
-
07.14.26 -- Moving Beyond Tactical Vendor Selection To Protect Capital Allocations
7/14/2026
07/14/26 Outsourced Pharma Newsletter
-
07.13.26 -- Stream Advanced Delivery, GMP Scale-Up, & Annex 1 Compliance
7/13/2026
07/13/26 Outsourced Pharma Newsletter
-
07.13.26 -- Evolving Relationship Structures For Reliable Drug Delivery
7/13/2026
07/13/26 Outsourced Pharma Newsletter
-
07.11.26 -- Outsourced Pharma Newsletter - Best Of June
7/11/2026
07/11/26 Outsourced Pharma Newsletter
-
07.10.26 -- In Palm Beach The Focus Is On Biotech (Not President Trump)
7/10/2026
07/10/26 Outsourced Pharma Newsletter
-
07.09.26 -- A Vaccine To Prevent Breast Cancer Recalibrates The Possible
7/9/2026
07/09/26 Outsourced Pharma Newsletter
-
07.08.26 -- Manufacturing Insights for Large Molecule Development
7/8/2026
07/08/26 Outsourced Pharma Newsletter
-
07.08.26 -- OPCU: Capabilities For Scaling Advanced Therapeutics
7/8/2026
07/08/26 Outsourced Pharma Newsletter
-
07.08.26 -- Rethinking Biotech Growth: Is More Capital the Answer?
7/8/2026
07/08/26 Outsourced Pharma Newsletter
-
07.07.26 -- Advancing Microbial Manufacturing And ADCs With CDMO Expertise
7/7/2026
07/07/26 Outsourced Pharma Newsletter